Cirrhosis, antibodies increase risk of poor outcome for autoimmune hepatitis patients

New research reports that cirrhosis at first diagnosis and antibodies for the soluble liver antigen/liver pancreas antigen (SLA/LP) are major risk factors for poor short- and long-term outcome in patients with autoimmune hepatitis. Scientists also found that patients diagnosed in childhood were at higher risk of relapse, need of a liver transplant, and reduced life expectancy.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1KrABcB